Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab effect on flu vaccine cellular response in RA
NCT01980836Phase 4Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Nov 2013
- Primary completion
- Feb 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of ARCT-2138 in influenza, sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
ARCT-2138
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01980836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01980836.